The State Council requires that the list of key monitored drugs be implemented nationwide

National implementation of key monitoring drug catalog - the State Council requires that all provinces formulate and issue key monitoring drug catalog by the end of December Recently, the State Council issued the notice of the leading group of the State Council on deepening the reform of the medical and health system on further promoting the experience of deepening the reform of the medical and health system in Fujian Province and Sanming City (hereinafter referred to as the notice) According to the notice of the State Council, all provinces shall formulate and issue the provincial key monitoring drug catalogue (chemical and biological products) by the end of December The notice requires strengthening the supervision and management of medical institutions, monitoring the hospital operation, the increase of the average cost of outpatient and inpatient times, the use of antibacterial drugs and auxiliary drugs, and increasing the notification and publicity of irrational drug use and other behaviors According to the notice, by the end of December 2019, each province shall formulate and issue the provincial key monitoring and rational drug use catalogue (chemical and biological products) and publish it By the end of December 2020, the key drug monitoring mechanism shall be fully established At the same time, all localities should strengthen the management and standardization of the drug catalog of medical institutions, guide and promote the timely adjustment and optimization of the drug catalog of all kinds of medical institutions at all levels, and promote the rational use of drugs Li Congxuan, general manager of OTC Business Department of Kangmei pharmaceutical industry, told saberland that the latest drug management law is the most stringent in history, and many of the penalties are not capped From this point of view, we can see that the next step of drug supervision will definitely be strengthened, the scope of the key monitoring drug catalog will be expanded, and the Chinese patent medicine will also be included The current situation of the Chinese patent medicine industry is that some Chinese patent medicines lack the barriers of access Whether it is the real estate area or not, the medicinal materials are planted A large number of Chinese patent medicine factories are built and put into production There is a phenomenon of disorderly competition and bad money expelling good money, Li Congxuan told cypress blue According to Li Congxuan, the scope of the key monitoring drug catalogue will be expanded and the management will be more and more strict, because the relevant departments must ensure the drug safety Another government official of a well-known domestic comprehensive pharmaceutical enterprise, who did not want to be named, said in an exchange with cypress blue that it is expected that the relevant departments of the state will definitely issue a second list of key monitoring drugs, and the relevant departments will manage the key monitoring drugs one round after another A few days ago, at the scene of a meeting, sepiland also learned from the authority in the field of drug regulation that, according to his judgment, the national drug regulation is undergoing a thorough transformation, not centered on industrial development, but on people's health He cautioned that some products with unclear efficacy need to be prepared, and they may face greater regulatory storm The key monitoring catalogue has a great impact on related drugs According to the above industry personage who did not want to be named, one of his company's varieties has seen sales drop by 50% due to its presence in the catalogue He further said that before the national version of the catalogue was published, there were catalogues of auxiliary drugs (key monitoring) in various provinces, and some of the use of drugs had been stopped In addition, many new drugs are on the market, even if the state does not limit the use of these drugs, their market will be affected.